Login / Signup
Investigational new drug approval of DA-1241: what we know about GPR119 targeting for MASH therapy?
Khaled Al Smadi
Ammar Qureshi
Besher Ashouri
Zeid Kayali
Published in:
Expert opinion on investigational drugs (2024)
Keyphrases
</>
cancer therapy
fatty acid
phase ii
emergency department
drug delivery
cell therapy